title: Leukotriene B4 is a physiologically relevant endogenous peroxisome proliferator-activated receptor-alpha agonist.
abstract: Peroxisome proliferator-activated receptors (PPARs) are nuclear transcription factors that play central roles in metabolism and inflammation. Although a variety of compounds have been shown to activate PPARs, identification of physiologically relevant ligands has proven difficult. In silico studies of lipid derivatives reported here identify specific 5-lipoxygenase products as candidate physiologically relevant PPAR-alpha activators. Subsequent studies show both in vitro and in a murine model of inflammation that 5-lipoxygenase stimulation induces PPAR-alpha signaling and that this results specifically from production of the inflammatory mediator and chemoattractant leukotriene B(4) (LTB(4)). Activation of PPAR-alpha is a direct effect of intracellularly generated LTB(4) binding to the nuclear receptor and not of secreted LTB(4) acting via its cell-surface receptors. Activation of PPAR-alpha reduces secretion of LTB(4) by stimulating degradation of this fatty acid derivative. We also show that the LTB(4) precursors leukotriene A(4) (LTA(4)) and 5-hydroperoxyeicosatetrenoic acid (5-HPETE) activate PPAR-alpha but have no significant endogenous effect independent of conversion to LTB(4). We conclude that LTB(4) is a physiologically relevant PPAR-alpha activator in cells of the immune system. This, together with previous findings, demonstrates that different types of lipids serve as endogenous PPAR-alpha ligands, with the relevant ligand varying between functionally different cell types. Our results also support the suggestion that regulation of inflammation may involve balancing proinflammatory effects of LTB(4), exerted through cell-surface receptors, and anti-inflammatory effects exerted through PPAR-alpha activation.
authors.affiliation: Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109-2200, USA.
authors.forename: Venkata R
authors.initials: VR
authors.lastname: Narala
authors.forename: Ravi K
authors.initials: RK
authors.lastname: Adapala
authors.forename: Madathilparambil V
authors.initials: MV
authors.lastname: Suresh
authors.forename: Thomas G
authors.initials: TG
authors.lastname: Brock
authors.forename: Marc
authors.initials: M
authors.lastname: Peters-Golden
authors.forename: Raju C
authors.initials: RC
authors.lastname: Reddy
mesh_terms: D000596:Amino Acids / Q000378:metabolism; D000818:Animals; D001094:Arachidonate 5-Lipoxygenase / Q000378:metabolism; D002460:Cell Line; D019295:Computational Biology; D006801:Humans; D007975:Leukotriene B4 / Q000096:biosynthesis / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D008024:Ligands; D051379:Mice; D008958:Models, Molecular; D047493:PPAR alpha / Q000819:agonists* / Q000737:chemistry / Q000378:metabolism
chemical_list: D000596:Amino Acids; D008024:Ligands; D047493:PPAR alpha; D007975:Leukotriene B4; D001094:Arachidonate 5-Lipoxygenase
references.citation: J Biol Chem. 2002 Jun 28;277(26):23278-86
references.pmid: 11956198
references.citation: Structure. 2001 Aug;9(8):699-706
references.pmid: 11587644
references.citation: J Exp Med. 2003 Aug 4;198(3):411-21
references.pmid: 12900517
references.citation: Int J Biochem Cell Biol. 1998 Feb;30(2):173-8
references.pmid: 9608670
references.citation: J Pharmacol Exp Ther. 2001 Nov;299(2):691-7
references.pmid: 11602682
references.citation: J Biol Chem. 2004 Aug 20;279(34):36093-102
references.pmid: 15190061
references.citation: Drug Metab Dispos. 2007 Jul;35(7):1126-34
references.pmid: 17431031
references.citation: Biochemistry. 1999 Jan 5;38(1):185-90
references.pmid: 9890897
references.citation: Nature. 1996 Nov 7;384(6604):39-43
references.pmid: 8900274
references.citation: J Clin Invest. 2003 Sep;112(6):945-55
references.pmid: 12975479
references.citation: Cell. 2009 Aug 7;138(3):476-88
references.pmid: 19646743
references.citation: J Biol Chem. 1998 Dec 4;273(49):32833-41
references.pmid: 9830030
references.citation: Eur J Biochem. 1992 Oct 1;209(1):281-9
references.pmid: 1327771
references.citation: Mol Endocrinol. 1997 Jun;11(6):779-91
references.pmid: 9171241
references.citation: J Biol Chem. 2006 Mar 17;281(11):7189-96
references.pmid: 16380383
references.citation: N Engl J Med. 2007 Nov 1;357(18):1841-54
references.pmid: 17978293
references.citation: Biochem Biophys Res Commun. 2000 Dec 20;279(2):520-5
references.pmid: 11118319
references.citation: Biochem Biophys Res Commun. 1981 Apr 30;99(4):1230-7
references.pmid: 6266415
references.citation: Biochemistry. 1991 Sep 24;30(38):9346-54
references.pmid: 1654095
references.citation: Circulation. 2007 Jan 30;115(4):518-33
references.pmid: 17261671
references.citation: Arch Biochem Biophys. 2007 May 1;461(1):104-12
references.pmid: 17418803
references.citation: Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4312-7
references.pmid: 9113986
references.citation: Biochim Biophys Acta. 2007 Aug;1771(8):915-25
references.pmid: 17317294
references.citation: J Biomed Biotechnol. 2004;2004(3):156-166
references.pmid: 15292582
references.citation: J Biol Chem. 2000 Sep 15;275(37):28918-28
references.pmid: 10844002
references.citation: Cell. 1995 Dec 1;83(5):803-12
references.pmid: 8521497
references.citation: Eur J Pharmacol. 2004 Sep 19;499(1-2):53-65
references.pmid: 15363951
references.citation: Biochem J. 2007 Aug 1;405(3):379-95
references.pmid: 17623009